Page 5 - Advanced Retinal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dec 18, 2020 06:00 UTC
Gyroscope Therapeutics and the University of Pennsylvania Announce Research Agreement to Develop Gene Therapies for Serious Eye Diseases
LONDON (Business Wire) Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on diseases of the eye, today announced the company has entered a sponsored research agreement with the University of Pennsylvania and the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to develop gene therapies for serious eye diseases that can lead to permanent vision loss. Gyroscope has an exclusive option to the intellectual property associated with, and arising from, the research conducted under the agreement.
A team of researchers from CAROT and Gyroscope will work together to explore specific gene therapy targets for glaucoma, optic neuritis and retinitis pigmentosa. The CAROT team is led by Jean Bennett, M.D., Ph.D., the F.M. Kirby Professor of Ophthalmology, along with Ken Shindler, M ....

University Of Pennsylvania , United States , City Of , United Kingdom , San Francisco , Charlotte Arnold , Tjean Bennett , Ahmara Ross , Khurem Farooq , Ken Shindler , Gyroscope Therapeutics , Drug Administration , Perelman School Of Medicine , Penn Center , Syncona Ltd , Cowen Equity Research Therapeutic Categories Outlook , Corporate Affairs , Business Wire , Gyroscope Therapeutics Limited , Advanced Retinal , Ocular Therapeutics , Associate Professor , Assistant Professor , Perelman School , Chief Executive Officer , Fast Track ,